Why do patients choose Israel for chemotherapy for prostate cancer?
Access advanced Chemotherapy for prostate cancer solutions in trusted clinics .
| Israel | Turkey | Austria | |
| Chemotherapy for prostate cancer | from $620 | from $1,000 | - |
Day 1: Arrival
Day 2: Pre-operation
Day 3: Chemotherapy
Day 4: Post-operation
Week 1-2: Rehabilitation
Week 3-4: Rehabilitation
Week 5-6: Rehabilitation
Week 6 and beyond: Final result
Please note: Each patient responds to treatment differently, this timeline is an estimate based on general patient experience.
As the leading global medical tourism platform, Bookimed.com provides information on Chemotherapy for prostate cancer in Israel grounded in research, foresight, and expertise. We have a huge responsibility to our clients — both patients and medical centers. All the information provided on Bookimed.com meets high interest related to the product and follows:
Our listings of clinics and doctors related to Chemotherapy for prostate cancer in Israel are formed with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
For Chemotherapy for prostate cancer in Israel, we collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience to find the best medical solutions from top medical services providers for Chemotherapy for prostate cancer in Israel just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces related to Chemotherapy for prostate cancer in Israel are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform related to Chemotherapy for prostate cancer in Israel is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com related to Chemotherapy for prostate cancer in Israel, please feel free to contact us at marketing@bookimed.com.
Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with decades of expertise in sarcoma and prostate cancer treatments.
Dr. Sarid specializes in chemotherapy for prostate cancer at Sourasky Medical Center, with over 38 years of experience of focused oncology experience.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.
He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.
Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.